Computational method for estimating progression saturation of analog series.

Area of Science:

• Medicinal Chemistry
• Computational Chemistry
• Drug Discovery

Background:

• Drug lead optimization involves synthesizing numerous analogs to improve compound properties.
• Determining when further analog synthesis is unlikely to yield progress (series saturation) is a significant challenge in drug discovery.
• Current methods for monitoring analog series progression and aiding decision-making are limited.

Purpose of the Study:

• To introduce a novel computational method for assessing analog series progression and saturation.
• To provide a data-driven approach for decision-making during lead optimization.
• To enhance the efficiency of drug discovery by identifying potentially unproductive analog synthesis efforts.

Main Methods:

• A new computational method was developed to evaluate analog series saturation.
• The method relates properties of existing compounds to those of potential synthetic candidates.
• It compares the distributions of these compounds within chemical space, analyzing analog neighborhoods and quantifying distance relationships.

Main Results:

• The computational method provides a quantitative assessment of analog series progression.
• It utilizes a dual scoring scheme to characterize analog series and their saturation levels.
• This approach allows for a more informed decision on whether to continue or terminate analog synthesis.

Conclusions:

• The developed computational method offers a valuable tool for assessing analog series saturation in lead optimization.
• It aids researchers in making more informed decisions, potentially saving time and resources.
• This approach can improve the efficiency and success rate of drug discovery programs.